NBIX Historical PE Ratio image   This NBIX PE ratio history page last updated 11/3/2022
NBIX Historical PE Ratio Chart
PeriodPriceAdj. EPSAnnualizedPE
Q3 2022
11/1/2022
119.361.084.3227.6
Q2 2022
8/4/2022
95.930.843.3628.6
Q1 2022
5/4/2022
88.400.301.2073.7
Q4 2021
2/11/2022
85.530.040.16>500
Q3 2021
11/1/2021
106.220.642.5641.5
Q2 2021
8/3/2021
97.700.632.5238.8
Q1 2021
5/5/2021
91.600.491.9646.7
Q4 2020
2/4/2021
114.550.913.6431.5
Q3 2020
11/9/2020
102.810.973.8826.5
Q2 2020
8/3/2020
123.011.425.6821.7
Q1 2020
5/6/2020
103.480.823.2831.5
Q4 2019
2/4/2020
103.101.054.2024.5
Q3 2019
11/4/2019
102.420.562.2445.7
Q2 2019
7/29/2019
86.970.321.2867.9
Q1 2019
4/29/2019
76.77-1.12-4.48NA
Q4 2018
2/5/2019
87.780.190.76115.5
Q3 2018
11/5/2018
110.550.522.0853.1
Q2 2018
7/31/2018
100.49-0.07-0.28NA
Q1 2018
4/30/2018
81.08-0.47-1.88NA
Q4 2017
2/13/2018
83.690.070.28298.9
Q3 2017
11/1/2017
60.93-0.13-0.52NA
Q2 2017
8/3/2017
48.84-0.68-2.72NA
Q1 2017
5/9/2017
52.60-0.90-3.60NA
Q4 2016
2/14/2017
41.53-0.51-2.04NA
Q3 2016
11/2/2016
42.56-0.43-1.72NA
Q2 2016
8/3/2016
50.34-0.46-1.84NA
Q1 2016
5/5/2016
42.65-0.22-0.88NA
Q4 2015
2/11/2016
35.37-0.34-1.36NA
Q3 2015
10/29/2015
49.97-0.40-1.60NA
Q2 2015
7/29/2015
50.66-0.28-1.12NA
Q1 2015
4/30/2015
34.09-0.01-0.04NA
Q4 2014
2/9/2015
33.54-0.26-1.04NA
Q3 2014
11/3/2014
18.15-0.21-0.84NA
Q2 2014
8/6/2014
13.82-0.18-0.72NA
Q1 2014
4/30/2014
14.02-0.17-0.68NA
Q4 2013
12/31/2013
9.34-0.16-0.64NA
Q3 2013
10/29/2013
10.67-0.17-0.68NA
Q2 2013
7/25/2013
14.00-0.18-0.72NA
Q1 2013
5/2/2013
10.90-0.18-0.72NA
Q4 2012
2/8/2013
10.840.140.5619.4
Q3 2012
10/31/2012
7.33-0.05-0.20NA
Q2 2012
7/31/2012
7.60-0.01-0.04NA
Q1 2012
5/2/2012
7.37-0.01-0.04NA
NBIX PE History Chart
PeriodPriceAdj. EPSTTMPE
Q3 2022
11/1/2022
119.361.082.2652.8
Q2 2022
8/4/2022
95.930.841.8252.7
Q1 2022
5/4/2022
88.400.301.6154.9
Q4 2021
2/11/2022
85.530.041.8047.5
Q3 2021
11/1/2021
106.220.642.6739.8
Q2 2021
8/3/2021
97.700.633.0032.6
Q1 2021
5/5/2021
91.600.493.7924.2
Q4 2020
2/4/2021
114.550.914.1227.8
Q3 2020
11/9/2020
102.810.974.2624.1
Q2 2020
8/3/2020
123.011.423.8532.0
Q1 2020
5/6/2020
103.480.822.7537.6
Q4 2019
2/4/2020
103.101.050.81127.3
Q3 2019
11/4/2019
102.420.56-0.05NA
Q2 2019
7/29/2019
86.970.32-0.09NA
Q1 2019
4/29/2019
76.77-1.12-0.48NA
Q4 2018
2/5/2019
87.780.190.17>500
Q3 2018
11/5/2018
110.550.520.05>500
Q2 2018
7/31/2018
100.49-0.07-0.60NA
Q1 2018
4/30/2018
81.08-0.47-1.21NA
Q4 2017
2/13/2018
83.690.07-1.64NA
Q3 2017
11/1/2017
60.93-0.13-2.22NA
Q2 2017
8/3/2017
48.84-0.68-2.52NA
Q1 2017
5/9/2017
52.60-0.90-2.30NA
Q4 2016
2/14/2017
41.53-0.51-1.62NA
Q3 2016
11/2/2016
42.56-0.43-1.45NA
Q2 2016
8/3/2016
50.34-0.46-1.42NA
Q1 2016
5/5/2016
42.65-0.22-1.24NA
Q4 2015
2/11/2016
35.37-0.34-1.03NA
Q3 2015
10/29/2015
49.97-0.40-0.95NA
Q2 2015
7/29/2015
50.66-0.28-0.76NA
Q1 2015
4/30/2015
34.09-0.01-0.66NA
Q4 2014
2/9/2015
33.54-0.26-0.82NA
Q3 2014
11/3/2014
18.15-0.21-0.72NA
Q2 2014
8/6/2014
13.82-0.18-0.68NA
Q1 2014
4/30/2014
14.02-0.17-0.68NA
Q4 2013
12/31/2013
9.34-0.16-0.69NA
Q3 2013
10/29/2013
10.67-0.17-0.39NA
Q2 2013
7/25/2013
14.00-0.18-0.27NA
Q1 2013
5/2/2013
10.90-0.18-0.10NA
Q4 2012
2/8/2013
10.840.140.07154.9
Q3 2012
10/31/2012
7.33-0.05NANA
Q2 2012
7/31/2012
7.60-0.01NANA
Q1 2012
5/2/2012
7.37-0.01NANA
Quotes delayed 20 minutes

Email EnvelopeFree NBIX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Neurocrine Biosciences (NBIX) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

NBSE PE Ratio History
NDRA PE Ratio History
NEO PE Ratio History
NEOG PE Ratio History
NERV PE Ratio History
NEXI PE Ratio History
NGM PE Ratio History
NKTR PE Ratio History
NKTX PE Ratio History
NLTX PE Ratio History
How should the NBIX historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Neurocrine Biosciences. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this NBIX Historical PE Ratio page.

What is the average historical PE for NBIX based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The NBIX historical PE ratio using the annualized quarterly earnings method works out to 58.4.

What is the average historical PE for NBIX based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The NBIX historical PE ratio using the TTM earnings method works out to 54.5.

What is the average historical PE for NBIX based on median TTM earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the median earnings over the trailing twelve months and annualize that median result in the calculation?

✔️Accepted answer: The NBIX historical PE ratio using the annualized median TTM earnings method works out to 2.28.

On this page we presented the NBIX Historical PE Ratio information for Neurocrine Biosciences' stock. The average NBIX historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 58.4. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average NBIX historical PE based on this TTM earnings result method is 54.5. Note: any PE calculations resulting in a value exceeding 500 were discarded as not meaningful. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this NBIX historical PE result, against the recent PE: when this page was posted on 11/2/2022, the most recent closing price for NBIX had been 122.06, and the most recent quarterly earnings result, annualized, was 4.32. Meanwhile, the most recent TTM earnings summed to 2.26. From these numbers, we calculate the recent NBIX PE on 11/2/2022 based on annualized quarterly EPS was 28.3. Based on NBIX's history, that recent PE is low relative to the historical average, with the recent PE 51.5% lower than the historical average PE across our data set for Neurocrine Biosciences. Looking at the recent NBIX PE on 11/2/2022 based on TTM EPS, we calculate the ratio at 54.0. Based on NBIX's history, that recent PE is low relative to the historical average, with the recent PE 0.9% lower than the average PE across our Neurocrine Biosciences data set with TTM EPS used in the calculation at each period.

Another interesting NBIX historical PE Ratio calculation we look at is to take the median earnings per share of the last four quarters for NBIX, and then annualize the resulting value... with that annualized number then being used in the PE calculation. To walk through this math for NBIX, we start with the past four EPS numbers and we first sort them from lowest to highest: 0.04, 0.30, 0.84, and 1.08. We then toss out the highest and lowest result, and then take the average of those two middle numbers — 0.30 and 0.84 — which gives us the median of 0.57. Basically the way to think about this 0.57 number is this: for the trailing four earnings reports, 0.57 marks the "middle ground" number where NBIX has reported a value higher than 0.57 half the time, and has reported a value lower than 0.57 half the time. Annualizing that median value then gets us to 2.28/share, which we use as the denominator in our next PE calculation. With 122.06 as the numerator (as of 11/2/2022), the calculation is then 122.06 / 2.28 = 53.5 as the NBIX PE ratio as of 11/2/2022, based on that annualized median value we calculated.

For self directed investors doing their due diligence on NBIX or any other given stock, valuation analysis for NBIX can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Neurocrine Biosciences PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for NBIX. Thanks for visiting, and the next time you need to research NBIX Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: Top Ten Hedge Funds Holding PNY, AIMT shares outstanding history, EBAY YTD Return.

 

NBIX Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.